{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:12:55Z","timestamp":1783941175788,"version":"3.55.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature cells capable of inhibiting T-cell responses. MDSCs have a crucial role in the regulation of the immune response of the body to pathogens, especially in inflammatory response and pathogenesis during anti-infection. Pathogens such as bacteria and viruses use MDSCs as their infectious targets, and even some pathogens may exploit the inhibitory activity of MDSCs to enhance pathogen persistence and chronic infection of the host. Recent researches have revealed the pathogenic significance of MDSCs in pathogens such as bacteria and viruses, despite the fact that the majority of studies on MDSCs have focused on tumor immune evasion. With the increased prevalence of viral respiratory infections, the resurgence of classical tuberculosis, and the advent of medication resistance in common bacterial pneumonia, research on MDSCs in these illnesses is intensifying. The purpose of this work is to provide new avenues for treatment approaches to pulmonary infectious disorders by outlining the mechanism of action of MDSCs as a biomarker and therapeutic target in pulmonary infectious diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1125737","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T06:06:54Z","timestamp":1680070014000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Advances in the study of myeloid-derived suppressor cells in infectious lung diseases"],"prefix":"10.3389","volume":"14","author":[{"given":"Meng-Nan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hua","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0986","article-title":"Upregulation of C\/EBP\u03b1 inhibits suppressive activity of myeloid cells and potentiates antitumor response in mice and patients with cancer","volume":"27","author":"Hashimoto","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15368","article-title":"Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma","volume":"8","author":"de Coa\u00f1a","year":"2017","journal-title":"Oncotarget."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e25242","DOI":"10.1371\/journal.pone.0025242","article-title":"Increased MDSC accumulation and Th2 biased response to influenza a virus infection in the absence of TLR7 in mice","volume":"6","author":"Jeisy-Scott","year":"2011","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/infdis\/jiaa708","article-title":"Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria","volume":"223","author":"Barbosa Bomfim","year":"2021","journal-title":"J Infect Diseases."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0123772","DOI":"10.1371\/journal.pone.0123772","article-title":"Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma level","volume":"10","author":"El Daker","year":"2015","journal-title":"Hoshino Y editor. PLoS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-0572-6","article-title":"Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)","volume":"27","author":"Agrati","year":"2020","journal-title":"Cell Death Differ"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e144734","DOI":"10.1172\/JCI144734","article-title":"Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity","volume":"131","author":"Falck-Jones","year":"2021","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202144","article-title":"Flagellin induces myeloid-derived suppressor cells: Implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease","volume":"190","author":"Rieber","year":"2013","journal-title":"JI."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00665-18","article-title":"Interleukin-10 produced by myeloid-derived suppressor cells provides protection to carbapenem-resistant klebsiella pneumoniae sequence type 258 by enhancing its clearance in the airways","volume":"87","author":"Pe\u00f1aloza","year":"2019","journal-title":"Infection Immunity."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.42.6.682","article-title":"Suppressor alveolar macrophages in mice bearing metastatic Lewis lung carcinoma tumors","volume":"42","author":"Young","year":"1987","journal-title":"J Leukoc Biol"},{"key":"B12","article-title":"Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors","volume":"47","author":"Young","year":"1987","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"17315","DOI":"10.1155\/2007\/17315","article-title":"Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor","volume":"2007","author":"van Cruijsen","year":"2007","journal-title":"Clin Dev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"425; author reply 426","DOI":"10.1158\/0008-5472.CAN-06-3037","article-title":"The terminology issue for myeloid-derived suppressor cells","volume":"67","author":"Gabrilovich","year":"2007","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.coi.2018.03.009","article-title":"Plasticity of myeloid-derived suppressor cells in cancer","volume":"51","author":"Tcyganov","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301365","article-title":"Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice","volume":"192","author":"Tsiganov","year":"2014","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix494","article-title":"Identification of a novel subset of myeloid-derived suppressor cells during chronic staphylococcal infection that resembles immature eosinophils","volume":"216","author":"Goldmann","year":"2017","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41419-020-03125-1","article-title":"Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome","volume":"11","author":"Sacchi","year":"2020","journal-title":"Cell Death Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.030811","article-title":"Cardioprotective role of myeloid-derived suppressor cells in heart failure","volume":"138","author":"Zhou","year":"2018","journal-title":"Circulation."},{"key":"B22","doi-asserted-by":"publisher","first-page":"200111","DOI":"10.1098\/rsob.200111","article-title":"Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine","volume":"10","author":"Yaseen","year":"2020","journal-title":"Open Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1610","article-title":"Blocking IL1 beta promotes tumor regression and remodeling of the myeloid compartment in a renal cell carcinoma model: Multidimensional analyses","volume":"27","author":"Aggen","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"104254","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-\u03b1 blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0507","article-title":"Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma","volume":"8","author":"Xiang","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-019-01237-9","article-title":"Adoptive transfer of IFN-\u03b3-induced m-MDSCs promotes immune tolerance to allografts through iNOS pathway","volume":"68","author":"Yang","year":"2019","journal-title":"Inflammation Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.4110\/in.2021.21.e21","article-title":"Mechanisms underlying the role of myeloid-derived suppressor cells in clinical diseases: Good or bad","volume":"21","author":"Ge","year":"2021","journal-title":"Immune Netw"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-015-0342-1","article-title":"Insights into myeloid-derived suppressor cells in inflammatory diseases","volume":"63","author":"Kwak","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"112346","DOI":"10.1016\/j.biopha.2021.112346","article-title":"Role of myeloid-derived suppressor cells in viral respiratory infections; hints for discovering therapeutic targets for COVID-19","volume":"144","author":"Koushki","year":"2021","journal-title":"Biomedicine Pharmacotherapy."},{"key":"B31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13613-021-00896-4","article-title":"Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: A pilot study","volume":"11","author":"Marais","year":"2021","journal-title":"Ann Intensive Care"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2009.03.021","article-title":"Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells","volume":"9","author":"Donkor","year":"2009","journal-title":"Int Immunopharmacol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2277-y","article-title":"MDSCs in infectious diseases: regulation, roles, and readjustment","volume":"68","author":"Dorhoi","year":"2019","journal-title":"Cancer Immunol Immunother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"109024","DOI":"10.1016\/j.clim.2022.109024","article-title":"Myeloid-derived suppressor cells in COVID-19: A review","volume":"238","author":"Perfilyeva","year":"2022","journal-title":"Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1101\/2021.03.26.21254441","article-title":"Transcriptome and functions of granulocytic myeloid-derived suppressor cells determine their association with disease severity of COVID-19","volume":"29","author":"Dean","year":"2021","journal-title":"medRxiv [Preprint]."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxab005","article-title":"Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan","volume":"33","author":"Takano","year":"2021","journal-title":"Int Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00920-5","article-title":"SARS-CoV-2-Induced ARDS associates with MDSC expansion, lymphocyte dysfunction, and arginine shortage","volume":"41","author":"Reizine","year":"2021","journal-title":"J Clin Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.614599","article-title":"Reduced expression of autophagy markers and expansion of myeloid-derived suppressor cells correlate with poor T cell response in severe COVID-19 patients","volume":"12","author":"Tomi\u0107","year":"2021","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.894543","article-title":"Monocytic-myeloid derived suppressor cells suppress T-cell responses in recovered SARS CoV2-infected individuals","volume":"13","author":"Beliakova-Bethell","year":"2022","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa577","article-title":"An inflammatory profile correlates with decreased frequency of cytotoxic cells in coronavirus disease 2019","volume":"71","author":"Bordoni","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e13108","DOI":"10.1111\/sji.13108","article-title":"Correlation of myeloid-derived suppressor cells with c-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19","volume":"95","author":"Emsen","year":"2022","journal-title":"Scandinavian J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202249827","article-title":"COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions","volume":"52","author":"Schrijver","year":"2022","journal-title":"Eur J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202571","article-title":"Elevated frequencies of CD14+HLA-DRlo\/neg MDSCs in COVID-19 patients","volume":"13","author":"Xue","year":"2021","journal-title":"Aging."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.3390\/cells10082111","article-title":"Expansion of myeloid derived suppressor cells contributes to platelet activation by l-arginine deprivation during SARS-CoV-2 infection","volume":"10","author":"Sacchi","year":"2021","journal-title":"Cells."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.801410","article-title":"Low levels of granulocytic myeloid-derived suppressor cells may be a good marker of survival in the follow-up of patients with severe COVID-19","volume":"12","author":"Jim\u00e9nez-Cortegana","year":"2021","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"109277","DOI":"10.1016\/j.intimp.2022.109277","article-title":"The function of myeloid-derived suppressor cells in COVID-19 lymphopenia","volume":"112","author":"Li","year":"2022","journal-title":"Int Immunopharmacol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.842535","article-title":"New discovery of myeloid-derived suppressor cell\u2019s tale on viral infection and COVID-19","volume":"13","author":"Park","year":"2022","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-3767","article-title":"Immature immunosuppressive CD14+HLA-DR-\/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign","volume":"70","author":"Poschke","year":"2010","journal-title":"Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40483","article-title":"Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells","volume":"120","author":"Chalmin","year":"2010","journal-title":"J Clin Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e2018587118","DOI":"10.1073\/pnas.2018587118","article-title":"Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity","volume":"118","author":"Kvedaraite","year":"2021","journal-title":"Proc Natl Acad Sci USA."},{"key":"B52","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.11.21249258","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with covid-19","volume":"384","author":"Gordon","year":"2021","journal-title":"N Engl J Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00099-0","article-title":"Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Lescure","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"109754","DOI":"10.1016\/j.mehy.2020.109754","article-title":"5-fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the coronavirus, COVID-19 infection","volume":"142","author":"Ahmad","year":"2020","journal-title":"Med Hypotheses."},{"key":"B57","doi-asserted-by":"publisher","first-page":"104259","DOI":"10.1016\/j.cellimm.2020.104259","article-title":"Effects of vitamin d on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients","volume":"360","author":"Kloc","year":"2021","journal-title":"Cell Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2100804","DOI":"10.1183\/13993003.00804-2021","article-title":"World health organization treatment outcome definitions for tuberculosis: 2021 update","volume":"58","author":"Linh","year":"2021","journal-title":"Eur Respir J"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02826","article-title":"Caveolin-1 controls vesicular TLR2 expression, p38 signaling and T cell suppression in BCG infected murine monocytic myeloid-derived suppressor cells","volume":"10","author":"John","year":"2019","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02417","article-title":"Human monocytic suppressive cells promote replication of mycobacterium tuberculosis and alter stability of in vitro generated granulomas","volume":"9","author":"Agrawal","year":"2018","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201405-0828OC","article-title":"Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis","volume":"190","author":"Knaul","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00018-022-04596-5","article-title":"Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system","volume":"79","author":"Singh","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1006640","article-title":"Mycobacteria-induced gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion","volume":"81","author":"Dietlin","year":"2007","journal-title":"J Leukoc Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e128664","DOI":"10.1172\/jci.insight.128664","article-title":"Heat-killed mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability","volume":"5","author":"Ribechini","year":"2019","journal-title":"JCI Insight"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201302-0249OC","article-title":"Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent Mycobacterium tuberculosis infection suppresses T-cell function","volume":"188","author":"Du Plessis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201410-1764ED","article-title":"Eat and suppress: The two-faced role of myeloid-derived suppressor cells in tuberculosis","volume":"190","author":"Rieber","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"104426","DOI":"10.1016\/j.cellimm.2021.104426","article-title":"Evaluation of autophagy mediators in myeloid-derived suppressor cells during human tuberculosis","volume":"369","author":"Kotze","year":"2021","journal-title":"Cell Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2017.10.009","article-title":"IFN-\u03b3 decreased the suppressive function of CD33+HLA-DRlow myeloid cells through down-regulation of PD-1\/PD-L2 signaling pathway","volume":"94","author":"Zhan","year":"2018","journal-title":"Mol Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4A0720-409RR","article-title":"Monocytic myeloid-derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase-2 inhibitors","volume":"110","author":"J\u00f8ntvedt J\u00f8rgensen","year":"2021","journal-title":"J Leukocyte Bio."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.841741","article-title":"Circulating monocyte-like myeloid derived suppressor cells and CD16 positive monocytes correlate with immunological responsiveness of tuberculosis patients","volume":"12","author":"Amiano","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.594376","article-title":"PMN-MDSC frequency discriminates active versus latent tuberculosis and could play a role in counteracting the immune-mediated lung damage in active disease","volume":"12","author":"Grassi","year":"2021","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676679","article-title":"The frequency and effect of granulocytic myeloid-derived suppressor cells on mycobacterial survival in patients with tuberculosis: A preliminary report","volume":"12","author":"Davids","year":"2021","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03189-21","article-title":"Myeloid-derived suppressor cells mediate T cell dysfunction in nonhuman primate TB granulomas","volume":"12","author":"Singh","year":"2021","journal-title":"Wormley FL editor. mBio."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00451","article-title":"Myeloid-derived suppressor cells as target of phosphodiesterase-5 inhibitors in host-directed therapeutics for tuberculosis","volume":"11","author":"Leukes","year":"2020","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660916","article-title":"Host-directed therapies: Modulating inflammation to treat tuberculosis","volume":"12","author":"Krug","year":"2021","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00772","article-title":"Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: A systematic review","volume":"8","author":"Kroesen","year":"2017","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.883886","article-title":"Sildenafil, a type-5 phosphodiesterase inhibitor, fails to reverse myeloid-derived suppressor cell-mediated T cell suppression in cells isolated from tuberculosis patients","volume":"13","author":"Leukes","year":"2022","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402518","article-title":"PcP ptomotes higher levels of infection and modulates recruitment of myeloid-derived suppressor cells during modulates recruitment","volume":"196","author":"Walker","year":"2016","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e1006955","DOI":"10.1371\/journal.ppat.1006955","article-title":"Clarithromycin expands CD11b+Gr-1+ cells via the STAT3\/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia","volume":"14","author":"Namkoong","year":"2018","journal-title":"PLoS Pathog"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02063.x","article-title":"Multiple anti-inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin b-induced lung injury: Therapeutic role of resveratrol in acute lung injury","volume":"167","author":"Rieder","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2012.62","article-title":"STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia","volume":"6","author":"Poe","year":"2013","journal-title":"Mucosal Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e89704","DOI":"10.1172\/jci.insight.89704","article-title":"Acquired resistance to innate immune clearance promotes klebsiella pneumoniae ST258 pulmonary infection","volume":"1","author":"Ahn","year":"2016","journal-title":"JCI Insight"},{"key":"B83","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.cmet.2022.03.009","article-title":"Klebsiella pneumoniae induces host metabolic stress that promotes tolerance to pulmonary infection","volume":"34","author":"Wong Fok Lung","year":"2022","journal-title":"Cell Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2016.00167","article-title":"Pseudomonas aeruginosa airway infection recruits and modulates neutrophilic myeloid-derived suppressor cells","volume":"6","author":"\u00d6z","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00668-12","article-title":"Accumulation of myeloid-derived suppressor cells in the lungs during pneumocystis pneumonia","volume":"80","author":"Zhang","year":"2012","journal-title":"Deepe GS editor. Infect Immun"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e53479","DOI":"10.1371\/journal.pone.0053479","article-title":"All-trans retinoic acid in combination with primaquine clears pneumocystis infection","volume":"8","author":"Lei","year":"2013","journal-title":"Steele C editor. PLoS One"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.02686-14","article-title":"Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during pneumocystis pneumonia","volume":"83","author":"Lei","year":"2015","journal-title":"Deepe GS editor. Infect Immun"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.737252","article-title":"Traditional Chinese medicine is an alternative therapeutic option for treatment of pseudomonas aeruginosa infections","volume":"12","author":"Pang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"225:107843","DOI":"10.1016\/j.pharmthera.2021.107843","article-title":"Traditional Chinese medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms","author":"Huang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.06.009","article-title":"Combating COVID-19 with integrated traditional Chinese and Western medicine in China","volume":"10","author":"Ni","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"B91","doi-asserted-by":"publisher","first-page":"112932","DOI":"10.1016\/j.jep.2020.112932","article-title":"Identifying potential treatments of COVID-19 from traditional Chinese medicine (TCM) by using a data-driven approach","volume":"258","author":"Ren","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"64","DOI":"10.13438\/j.cnki.jdzk.2022.05.011","article-title":"Investigation of the mechanism of coptis chinensis for the treatment of COVID-19 based on network pharmacology and molecular docking","volume":"43","author":"Feng","year":"2022","journal-title":"J Jishou Univ (Natural Sci Edition)"},{"key":"B93","article-title":"Explore mechanism of blood components lonicera japonica flos intervening COVID-19 based on network pharmacology and molecular docking technology","volume":"37","author":"Liu","year":"2022","journal-title":"Drugs Clinic."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7012","article-title":"Exploring the treatment of COVID-19 with yinqiao powder based on network pharmacology","volume":"35","author":"Lin","year":"2021","journal-title":"Phytother Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.10.002","article-title":"Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B96","doi-asserted-by":"publisher","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Runfeng","year":"2020","journal-title":"Pharmacol Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"115368","DOI":"10.1016\/j.jep.2022.115368","article-title":"The licorice flavonoid isoliquiritigenin attenuates mycobacterium tuberculosis-induced inflammation through Notch1\/NF-\u03baB and MAPK signaling pathways","volume":"294","author":"Sun","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"B98","article-title":"Effects of curcuma longa l., eucommia ulmoides oliv. and gynostemma pentaphyllum (Thunb.) makino on cytokine production in stimulated peripheral blood mononuclear cells in patients with tuberculosis","volume":"28","author":"Chuang","year":"2022","journal-title":"Altern Ther Health Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e1008887","DOI":"10.1371\/journal.ppat.1008887","article-title":"Luteolin-mediated Kv1.3 k+ channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice","volume":"16","author":"Singh","year":"2020","journal-title":"PLoS Pathog"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e0203678","DOI":"10.1371\/journal.pone.0203678","article-title":"Protective immune mechanisms of yifei tongluo, a Chinese herb formulation, in the treatment of mycobacterial infection","volume":"13","author":"Fan","year":"2018","journal-title":"PLoS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"635152","DOI":"10.1155\/2014\/635152","article-title":"The inhibition of folylpolyglutamate synthetase (folC) in the prevention of drug resistance in mycobacterium tuberculosis by traditional Chinese medicine","volume":"2014","author":"Hung","year":"2014","journal-title":"BioMed Res Int"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2016.03.002","article-title":"Qingfei xiaoyan wan, a traditional Chinese medicine formula, ameliorates pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K\/AKT and Ras\/MAPK pathways","volume":"6","author":"Hou","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e0176883","DOI":"10.1371\/journal.pone.0176883","article-title":"Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model","volume":"12","author":"Luo","year":"2017","journal-title":"PLoS One"},{"key":"B104","doi-asserted-by":"publisher","first-page":"112272","DOI":"10.1016\/j.jep.2019.112272","article-title":"Chinese Medicinal herb extract inhibits PQS-mediated quorum sensing system in pseudomonas aeruginosa","volume":"248","author":"Wei","year":"2020","journal-title":"J Ethnopharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1125737\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T06:06:59Z","timestamp":1680070019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1125737\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":104,"alternative-id":["10.3389\/fimmu.2023.1125737"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1125737","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"article-number":"1125737"}}